Anti-Microbial/Anti-fungal Test Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Anti-Microbial/Anti-fungal Test Market covers analysis By Test Type (Molecular Based Tests, Rapid Diagnostic Tests, complex Test, Phenotypic Resistance Tests, Others); Infection Type (Microbial Infection, Fungal Infection, Anti-Microbial Resistance, Anti-Fungal Resistance); End User (Hospitals and Clinics, Diagnostic Centers, Research Laboratories) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00005376
  • Category : Biotechnology
  • No. of Pages : 150
Buy Now

Anti-Microbial/Anti-fungal Test Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

MARKET OVERVIEW

An antimicrobial is an agent that kills microorganisms or stops their growth in body. In these antibiotics are used against bacteria and antifungals are used against fungi. The use of antimicrobial medicines to treat infection is known as antimicrobial chemotherapy, while the use of antimicrobial medicines to prevent infection is known as antimicrobial prophylaxis. Antimicrobial susceptibility tests can guide the physician in drug choice and dosage for difficult-to-treat infections.

MARKET SCOPE

The "Global Anti-Microbial/Anti-Fungal Test Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the anti-microbial/anti-fungal test market with detailed market segmentation by test type, infection type, end user, and geography. The report provides key statistics on the market status of the leading anti-microbial/anti-fungal test market players and offers key trends and opportunities in the market.


MARKET SEGMENTATION

  •   Based on test type, the market is segmented as molecular based tests, rapid diagnostic tests, complex test, phenotypic resistance tests and others.
  •   On the basis of infection type, the global anti-microbial/anti-fungal test market is segmented microbial infection, fungal infection, anti-microbial resistance and anti-fungal resistance.
  •   Based on the end user the market is segmented into hospitals and clinics, diagnostic centers and research laboratories.

MARKET DYNAMICS
Drivers:

  •   Rising infectious disease
  •   Increasing incidences of surgical site infections and others
  •   Advancements in the diagnostic techniques by the use of biotechnology

Restraints:

  •   Lack of innovation culture
  •   Lack of skilled professionals

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The anti-microbial/anti-fungal test market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the anti-microbial/anti-fungal test market in these regions.

IMPACT OF COVID-19 ON ANTI-MICROBIAL/ANTI-FUNGAL TEST MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

Anti-Microbial/Anti-fungal Test Market Report Analysis

Anti-Microbial/Anti-fungal Test Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX Million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • bioMerieux, SA
  • Thermo Fisher Scientific Inc
  • Qiagen N. V
  • Bio-Rad Laboratories Inc
  • F. Hoffmann-La Roche Ltd
  • Erba Mannheim
  • Omega Diagnostics Group Plc
  • Quidel Corporation
  • Luminex Corporation

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

By Test Type
  • Molecular Based Tests
  • Rapid Diagnostic Tests
  • complex Test
  • Phenotypic Resistance Tests
  • Others
By Infection Type
  • Microbial Infection
  • Fungal Infection
  • Anti-Microbial Resistance
  • Anti-Fungal Resistance
By End User
  • Hospitals and Clinics
  • Diagnostic Centers
  • Research Laboratories
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
MARKET PLAYERS


The report covers key developments in the anti-microbial/anti-fungal test market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from anti-microbial/anti-fungal test market are anticipated to lucrative growth opportunities in the future with the rising demand for anti-microbial/anti-fungal test in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the anti-microbial/anti-fungal test market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   bioMerieux, Inc
  •   Thermo Fisher Scientific Inc
  •   Qiagen N. V
  •   Bio-Rad Laboratories Inc
  •   F. Hoffmann-La Roche Ltd
  •   Erba Mannheim
  •   Omega Diagnostics Group Plc
  •   Quidel Corporation
  •   Luminex Corporation
  •   Norgen Biotek Corp
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Anti-Microbial/Anti-fungal Test Market Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Test Type
  • Molecular Based Tests
  • Rapid Diagnostic Tests
  • complex Test
  • Phenotypic Resistance Tests
  • Others
By Infection Type
  • Microbial Infection
  • Fungal Infection
  • Anti-Microbial Resistance
  • Anti-Fungal Resistance
By End User
  • Hospitals and Clinics
  • Diagnostic Centers
  • Research Laboratories
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • bioMerieux, SA
  • Thermo Fisher Scientific Inc
  • Qiagen N. V
  • Bio-Rad Laboratories Inc
  • F. Hoffmann-La Roche Ltd
  • Erba Mannheim
  • Omega Diagnostics Group Plc
  • Quidel Corporation
  • Luminex Corporation
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    The List of Companies

    1. bioMerieux, SA
    2. Thermo Fisher Scientific Inc
    3. Qiagen N. V
    4. Bio-Rad Laboratories Inc
    5. F. Hoffmann-La Roche Ltd
    6. Erba Mannheim
    7. Omega Diagnostics Group Plc
    8. Quidel Corporation
    9. Luminex Corporation
    10. Norgen Biotek Corp
    11. Abbott Laboratories
    12. Bruker Corporation
    13. Danaher Corporation
    14. Erba Mannheim.
    15. Meridian Bioscience Inc

    Trends and growth analysis reports related to Biotechnology : READ MORE..